Quinoa as source of type 1 ribosome inactivating proteins: A novel knowledge for a revision of its consumption.

ATP assay Chenopodium quinoa Willd. Protein purification Ribosome inactivating proteins rRNA N-glycosylase

Journal

Food chemistry
ISSN: 1873-7072
Titre abrégé: Food Chem
Pays: England
ID NLM: 7702639

Informations de publication

Date de publication:
16 Apr 2021
Historique:
received: 20 08 2020
revised: 05 10 2020
accepted: 06 10 2020
pubmed: 21 10 2020
medline: 5 2 2021
entrez: 20 10 2020
Statut: ppublish

Résumé

This study investigates on the presence of toxic proteins in quinoa seeds. To this aim, a plethora of biochemical approaches were adopted for the purification and characterization of quinoin, a type 1 ribosome-inactivating protein (RIP) contained in quinoa seeds. We determined its melting temperature (68.2 ± 0.6 °C) and thermostability (loss of activity after 10-min incubation at 70 °C). Considering that quinoa seeds are used as a food, we found that quinoin is cytotoxic against BJ-5ta (human fibroblasts) and HaCaT (human keratinocytes) in a dose- and time-dependent manner. Moreover, in an in vitro digestive pepsin-trypsin treatment, 30% of quinoin is resistant to enzymatic cleavage. This toxin was found in seeds (0.23 mg/g of seeds) and in sprouted seeds obtained after 24-h (0.12 mg/g of sprout) and 48-h (0.09 mg/g of sprout). We suggest a thermal treatment of quinoa seeds before consumption in order to inactivate the toxin, particularly in sprouts, generally consumed raw.

Identifiants

pubmed: 33077288
pii: S0308-8146(20)32199-3
doi: 10.1016/j.foodchem.2020.128337
pii:
doi:

Substances chimiques

Ribosome Inactivating Proteins, Type 1 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

128337

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Nicola Landi (N)

Department of Environmental, Biological and Pharmaceutical Sciences and Technologies (DiSTABiF), University of Campania 'Luigi Vanvitelli', Via Vivaldi 43, 81100 Caserta, Italy.

Maria Rosaria Ruocco (MR)

Department of Molecular Medicine and Medical Biotechnology, University of Naples 'Federico II', Via S. Pansini 5, 80131 Naples, Italy.

Sara Ragucci (S)

Department of Environmental, Biological and Pharmaceutical Sciences and Technologies (DiSTABiF), University of Campania 'Luigi Vanvitelli', Via Vivaldi 43, 81100 Caserta, Italy.

Federica Aliotta (F)

Department of Molecular Medicine and Medical Biotechnology, University of Naples 'Federico II', Via S. Pansini 5, 80131 Naples, Italy.

Rosarita Nasso (R)

Department of Movement Sciences and Wellness, University of Naples 'Parthenope', Via F. Acton 38, 80133 Naples, Italy.

Paolo V Pedone (PV)

Department of Environmental, Biological and Pharmaceutical Sciences and Technologies (DiSTABiF), University of Campania 'Luigi Vanvitelli', Via Vivaldi 43, 81100 Caserta, Italy.

Antimo Di Maro (A)

Department of Environmental, Biological and Pharmaceutical Sciences and Technologies (DiSTABiF), University of Campania 'Luigi Vanvitelli', Via Vivaldi 43, 81100 Caserta, Italy. Electronic address: antimo.dimaro@unicampania.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH